Source comparison
BPC-157 Tissue Repair Protocol: Dosing & Timeline Comparison
Tendon injuries (Achilles, patellar, rotator cuff) 200–300mcg Twice daily, 12 hours apart 6–8 weeks Low vascularity requires sustained low-dose signalling; avoid direct tendon injection Muscle strains & tears (hamstring, quadriceps, gastrocnemius) 400–500mcg 4
This comparison does not assign a generated winner or score.
- Tendon injuries (Achilles, patellar, rotator cuff)
- 200–300mcg
- Twice daily, 12 hours apart
- 6–8 weeks
- Low vascularity requires sustained low-dose signalling; avoid direct tendon injection
- Muscle strains & tears (hamstring, quadriceps, gastrocnemius)
- 400–500mcg
- 4–6 weeks
- High metabolic turnover clears peptide faster; higher doses compensate for rapid clearance
- Ligament injuries (ACL, MCL, ankle sprains)
- 300–400mcg
- Ligament vascularity varies; dose at upper range for poorly vascularised structures
- Joint cartilage damage (meniscus, labral tears)
- 250–350mcg per site, 2–3 sites around joint
- 8–12 weeks
- Multiple injection sites ensure peptide distribution; cartilage repair is slowest tissue type
- Bone fractures (adjunct to medical treatment)
- 300–400mcg near fracture site
- 4–6 weeks post-cast removal
- Begin during remodelling phase, not acute healing; supports callus formation
- Professional Assessment
- Dosing must account for injury severity, tissue depth, vascularisation, and inflammatory phase. Flat-dose protocols ignore the variables that determine therapeutic efficacy